Opko Health OPK
NASDAQ OPK
$1.73 +0.04 (+2.41%)
As of: Sep 22, 2026 · 10:07 AM EDT

Opko Health (OPK) Income towards Parent Company (2010 - 2026)

Opko Health's (OPK) quarterly Income towards Parent Company came in at -$8.4 million in Q2 2026, up 94.33% on a YoY basis from -$4.3 million in Q2 2025, and up 84.66% quarter-over-quarter from -$54.8 million in Q1 2026.

Analysis

Opko Health (OPK) Income towards Parent Company (2010 - 2026) Analysis & Trends

Opko Health (OPK) has reported Income towards Parent Company for 17 consecutive years, with -$8.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Income towards Parent Company rose 94.33% year-over-year to -$8.4 million; the trailing twelve-month figure through Jun 2026 stood at -$37.9 million (up 86.63% YoY), and the FY2025 full-year result was -$190.7 million, down 258.37% from the prior year.
  • Income towards Parent Company improved to -$8.4 million in Q2 2026 per OPK's latest filing, from -$54.8 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $24.9 million in Q3 2024 and bottomed at -$148.4 million in Q2 2025.
  • Historically, Income towards Parent Company has averaged -$54.1 million across 5 years, with a median of -$66.5 million in 2023.
  • The sharpest annual moves came in 2022 and 2024: Income towards Parent Company plunged 528.96% in 2022, then surged 129.48% in 2024.
  • Over 5 years, Income towards Parent Company stood at -$85.2 million in 2022, then gained by 21.98% to -$66.5 million in 2023, then soared by 137.45% to $24.9 million in 2024, then tumbled by 84.98% to $3.7 million in 2025, then plunged by 325.09% to -$8.4 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$8.4 million, -$54.8 million, and $3.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.42 Mn
Mar 31, 2026 -54.85 Mn
Dec 31, 2025 3.74 Mn
Sep 30, 2025 21.63 Mn
Jun 30, 2025 -148.44 Mn
Mar 31, 2025 -67.60 Mn
Sep 30, 2024 24.89 Mn
Jun 30, 2024 -92.14 Mn
Mar 31, 2024 -81.83 Mn
Dec 31, 2023 -66.48 Mn
Sep 30, 2023 -84.45 Mn
Jun 30, 2023 -19.60 Mn
Mar 31, 2023 -18.23 Mn
Dec 31, 2022 -85.21 Mn
Sep 30, 2022 -86.05 Mn
Jun 30, 2022 -101.38 Mn
Mar 31, 2022 -55.38 Mn
Dec 31, 2021 -73.31 Mn
Sep 30, 2021 28.79 Mn
Jun 30, 2021 -16.12 Mn
API Access

Opko Health Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=OPK&period=max&api_key=YOUR_API_KEY